Kathryn Logronio

613 total citations
11 papers, 455 citations indexed

About

Kathryn Logronio is a scholar working on Oncology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kathryn Logronio has authored 11 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Immunology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kathryn Logronio's work include CAR-T cell therapy research (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and T-cell and B-cell Immunology (3 papers). Kathryn Logronio is often cited by papers focused on CAR-T cell therapy research (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and T-cell and B-cell Immunology (3 papers). Kathryn Logronio collaborates with scholars based in United States and Netherlands. Kathryn Logronio's co-authors include John Lin, Guang Huan Tu, Li‐Fen Lee, Winston Evering, Shihao Chen, Hui Wang, Todd VanArsdale, Mark Elliott, Bart Jessen and Ying Chi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Cancer Research.

In The Last Decade

Kathryn Logronio

11 papers receiving 443 citations

Peers

Countries citing papers authored by Kathryn Logronio

Since Specialization

Citations

This map shows the geographic impact of Kathryn Logronio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Logronio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Logronio more than expected).

Fields of papers citing papers by Kathryn Logronio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn Logronio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Logronio. The network helps show where Kathryn Logronio may publish in the future.

Co-authorship network of co-authors of Kathryn Logronio

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Logronio. A scholar is included among the top collaborators of Kathryn Logronio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Logronio. Kathryn Logronio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	IGM-7354, an Immunocytokine with IL15 Fused to an Anti–PD-L1 IgM, Induces NK and CD8+ T cell–Mediated Cytotoxicity of PD-L1–Positive Tumor Cells 2025 ·Cancer Immunology Research ·Mélanie Desbois, Thierry Giffon, (unknown), (unknown), (unknown), Kevin C. Hart, Daniel Santos, (unknown), Kathryn Logronio, (unknown), Dean Ng, Avneesh K. Saini, (unknown), Bruce A. Keyt, Angus M. Sinclair, Maya F. Kotturi	1
2	Combination of Imvotamab and Loncastuximab Tesirine Shows Enhanced Anti‐Tumor Activity in a Preclinical Model of Non‐Hodgkin’s Lymphoma 2023 ·Hematological Oncology ·Kathryn Logronio, (unknown), Miho Oyasu, (unknown), (unknown), Genevive Hernandez, Thomas Manley, Angus M. Sinclair, Stephen F. Carroll, Albert F. Candia, Bruce A. Keyt, (unknown)	1
3	Novel CD123xCD3 Bispecific Igm Antibody, Igm-2537, Potently Induces T-Cell Mediated Cytotoxicity of Acute Myeloid Leukemia Cells In Vivo and in Vitro with Minimal Cytokine Release 2023 ·Blood ·(unknown), Zhongde Ye, (unknown), (unknown), Kathryn Logronio, (unknown), (unknown), (unknown), Paul R. Hinton, (unknown), (unknown), (unknown), Maya F. Kotturi, (unknown), (unknown), (unknown), Thomas Manley, Bruce A. Keyt, Angus M. Sinclair, Liqin Liu	1
4	Abstract 4179: High valency of IGM-2323, a CD20xCD3 IgM bispecific T cell engager, displaces rituximab binding and induces potent B lymphoma cell killing 2022 ·Cancer Research ·Kevin C. Hart, Kathryn Logronio, (unknown), (unknown), (unknown), Keyu Li, Paul R. Hinton, Dean Ng, Maya K. Leabman, Genevive Hernandez, Thomas Manley, Angus M. Sinclair, Stephen F. Carroll, Bruce A. Keyt, Maya F. Kotturi	1
5	COM902, a novel therapeutic antibody targeting TIGIT augments anti-tumor T cell function in combination with PVRIG or PD-1 pathway blockade 2021 ·Cancer Immunology Immunotherapy ·Kyle Hansen, Sandeep Kumar, Kathryn Logronio, Sarah Whelan, (unknown), Hsin‐Yuan Cheng, (unknown), (unknown), Patrick D. Wall, (unknown), Ling Leung, Eran Ophir, Zoya Alteber, Gady Cojocaru, (unknown), (unknown), Mark A. White, John Hunter, Spencer C. Liang, Maya F. Kotturi	29
6	841P IGM-2323 is a CD20xCD3 IgM bispecific T-cell engager that kills low CD20-expressing and rituximab-resistant B-cell lymphomas 2021 ·Annals of Oncology ·(unknown), Maya F. Kotturi, (unknown), (unknown), Paul R. Hinton, Kathryn Logronio, Ramesh Baliga, Genevive Hernandez, Angus M. Sinclair, (unknown), Wayne R. Godfrey, Bruce A. Keyt	1
7	Combination of 4-1BB Agonist and PD-1 Antagonist Promotes Antitumor Effector/Memory CD8 T Cells in a Poorly Immunogenic Tumor Model 2014 ·Cancer Immunology Research ·Shihao Chen, Li‐Fen Lee, Timothy S. Fisher, Bart Jessen, Mark Elliott, Winston Evering, Kathryn Logronio, Guang Huan Tu, Konstantinos Tsaparikos, (unknown), Hui Wang, Ying Chi, (unknown), Todd VanArsdale, John Lin	207
8	Anti–IL-7 receptor-α reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function 2012 ·Proceedings of the National Academy of Sciences ·Li‐Fen Lee, Kathryn Logronio, Guang Huan Tu, Wenwu Zhai, Irene Ni, Mei Li, Jeanette Dilley, Jessica Yu, Arvind Rajpal, Colleen Brown, (unknown), Sherman M. Chin, Bora Han, (unknown), John Lin	110
9	IL-7 Promotes T _H 1 Development and Serum IL-7 Predicts Clinical Response to Interferon-β in Multiple Sclerosis 2011 ·Science Translational Medicine ·Li‐Fen Lee, Robert C. Axtell, Guang Huan Tu, Kathryn Logronio, Jeanette Dilley, Jessica Yu, Mathias Rickert, Bora Han, Winston Evering, Michael G. Walker, Jing Shi, Brigit A. de Jong, Joep Killestein, Chris H. Polman, Lawrence Steinman, John Lin	89
10	A chromosome 16 quantitative trait locus regulates allogeneic bone marrow engraftment in nonmyeloablated mice 2009 ·Blood ·Thai M. Cao, Alun Thomas, Yuanyuan Wang, Schickwann Tsai, Kathryn Logronio, Judith A. Shizuru	3
11	Purified hematopoietic stem cell allografts reconstitute immunity superior to bone marrow 2009 ·Proceedings of the National Academy of Sciences ·(unknown), Jessica A. Allen, Kathryn Logronio, Laura C. Lazzeroni, Judith A. Shizuru	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact